Molecular Templates, Inc. (MTEM)

Molecular Templates Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-8.12	-92.72	-83.01	-104.92	-69.42
Depreciation & Amortization	6.65	7.38	6.63	3.92	1.18
Share-Based Compensation	6.7	11.91	16.63	11.82	5.86
Other Operating Activities	-47.04	-15.6	29.36	5.39	37.14
Operating Cash Flow	-41.82	-89.02	-30.39	-83.8	-25.24
Capital Expenditures	0.06	-3.2	-4	-7.38	-9.65
Change in Investments	29.04	98.52	-58.44	-27.29	-30.08
Investing Cash Flow	29.1	95.32	-62.44	-34.66	-39.72
Share Issuance / Repurchase	18.38	0.03	72.77	49.41	65.67
Debt Issued / Paid	-27.5	-0.3	19.83	9.48	0.03
Financing Cash Flow	-9.12	-0.27	92.59	58.9	65.7
Net Cash Flow	-21.84	6.03	-0.24	-59.57	0.73
Free Cash Flow	-41.76	-92.22	-34.38	-91.17	-34.89
Free Cash Flow Margin	-72.87%	-466.85%	-88.85%	-483.81%	-156.68%
Free Cash Flow Per Share	-9.28	-24.56	-9.33	-28.73	-13.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).